Intercept-Sumitomo completes liver cirrhosis drug's phase II trials
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015
Tokyo: Intercept Pharmaceuticals Inc has announced the results of a 72-week phase II dose ranging trial of obeticholic a...Read more
PPD partners with CISYS LifeSciences
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015
Pharmaceutical Product Development(PPD) and CISYS LifeSciences has announced PPD's implementation of Sequence WebEAS, a ...Read more
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012
Singapore: QPS Holdings, a leading full-service clinical research organization, announced the launch of its QPS Qualiti...Read more
Cellmid gets positive data in midkine study
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013
Singapore: Cellmid has completed its first in-life diabetic nephropathy study with the company's anti-midkine antibodie...Read more
Sanofi's dengue vaccine candidate shows positive results
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2012
Singapore: Sanofi Pasteur, the vaccines division of Sanofi has published clinical study results of its dengue vaccine ca...Read more
The evolving clinical trial landscape of Asia
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015
Singapore: At a recent Pharma CI Conference & Exhibition Asia held in Tokyo, Citeline, a leading research authority ...Read more
Quest Life Sciences receives WHO notice: Reports
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2015
Singapore: According to reports, Quest Life Sciences has received a 'notice of concern', or NoC from the World Health Or...Read more
AMA receives new clinical trials registry
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 20 May, 2015
The Australian Medical Association (AMA) has welcomed a new register for clinical trials in the country for patients to ...Read more
Chugai opens North American Hub in New Jersey
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2015
Tokyo: Chugai Pharma USA Inc. (CPUSA), a wholly-owned subsidiary of Japan's Chugai Pharmaceutical Co Ltd. has officially...Read more
OxOnc, Pfizer drug trial to be held in Asia
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2013
Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...Read more
Japan Pharma Manufacturers Association partners with Medidata
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 01 Sep, 2015
Singapore: Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutic...Read more
A re-think on site staff competency training required
Clinical Research | Opinion | By BioSpectrum Bureau | 3 Comment | 05 Sep, 2013
When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...Read more
Catalent Pharma opens new clinical supply facility in Japan
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2016
Tokyo: New Jersey-headquartered Catalent Pharma Solutions, the leading global provider of advanced delivery technologies...Read more
Strong clinical trial infrastructure puts Australia in a strong position
Clinical Research | Opinion | By BioSpectrum Bureau | 3 Comment | 11 Sep, 2013
Australia's strong history of quality and experience in clinical research is well known, and whilst being a comparativ...Read more
Crizotinib phase II study in East Asian Patients meets end point expectations
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2016
OxOnc Development LP has announced that Study OO-1201, a phase II open-label, single-arm study of crizotinib in East Asi...Read more
BSA-CMR Survey: Asian CROs optimistic in a gloomy pharma market
Clinical Research | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...Read more
Cogstate bets big on its cognitive test Cognigram
Clinical Research | Company results | By BioSpectrum Bureau | 7 Comment | 20 Feb, 2013
Singapore: Australian company Cogstate has earned overall revenue of $6.14 million and a net loss of $0.49 million in th...Read more
Parexel acquires regulatory info firm Liquent
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2012
Singapore: Parexel International has acquired all of the outstanding equity securities of Liquent, a leading global prov...Read more